background
hepat
c
viru
major
caus
chronic
liver
diseas
lead
perman
liver
damag
hepatocellular
carcinoma
death
present
avail
treatment
interferon
plu
ribavirin
limit
benefit
due
advers
side
effect
anemia
depress
fatigu
flulik
symptom
herbal
plant
use
centuri
differ
diseas
includ
viral
diseas
becom
major
sourc
new
compound
treat
bacteri
viral
diseas
materi
present
studi
design
studi
antivir
effect
glycyrrhizin
gl
hcv
purpos
hcv
infect
liver
cell
treat
gl
non
toxic
dose
hcv
titer
measur
quantit
real
time
rtpcr
result
demonstr
gl
inhibit
hcv
titer
dose
depend
manner
result
reduct
hcv
concentr
compar
studi
made
interferon
alpha
investig
synergist
effect
antivir
compound
interferon
alpha
data
show
gl
exhibit
synergist
effect
combin
interferon
moreov
result
verifi
transient
transfect
liver
cell
hcv
core
plasmid
result
prove
gl
dose
depend
inhibit
express
hcv
core
gene
mrna
protein
level
gapdh
remain
constant
result
suggest
gl
inhibit
hcv
full
length
viral
particl
hcv
core
gene
express
function
dose
depend
manner
synergist
effect
interferon
futur
gl
along
interferon
better
option
treat
hcv
infect
hepat
c
viru
hcv
major
caus
liver
associ
diseas
world
estim
world
popul
million
peopl
chronic
infect
hcv
main
caus
liver
fibrosi
cirrhosi
hepatocellular
carcinoma
hcc
like
rna
virus
hcv
possess
high
degre
sequenc
variabl
like
contribut
abil
establish
chronic
infect
mild
acut
phase
current
treatment
standard
hcv
compris
combin
highdos
pegyl
interferon
alpha
guanosin
analogu
ribavirin
rib
patient
receiv
therapeut
benefit
current
combin
therapi
pegifn
guanosin
analog
ribavirin
advers
side
effect
high
cost
vaccin
develop
hinder
lack
good
invitro
invivo
model
infect
antigen
heterogen
viru
abil
avoid
immun
defens
henc
need
develop
antivir
drug
treat
hepat
infect
plant
sourc
hcv
envelop
positivestrand
rna
viru
belong
hepaciviru
genu
flavivirida
famili
hcv
six
major
genotyp
approxim
subtyp
depend
geograph
distribut
viru
hcv
genom
encod
singl
polyprotein
precursor
approxim
amino
acid
residu
replic
cytosol
negativestrand
intermedi
intern
ribosom
entri
site
ire
drive
translat
polyprotein
coand
posttransl
process
cellular
viral
proteas
yield
matur
viral
structur
protein
core
nonstructur
protein
addit
protein
produc
ribosom
frameshift
ntermin
region
polyprotein
hcv
structur
protein
core
nonstructur
protein
proteas
rnadepend
rna
polymeras
potent
molecular
target
new
antivir
compound
glycyrrhiza
glabra
perenni
herb
nativ
central
southwestern
asia
well
mediterranean
region
cultiv
temper
subtrop
region
world
includ
europ
asia
dri
root
glycyrrhiza
glabra
characterist
odour
sweet
tast
antiinflammatori
antioxid
immunomodulatori
activ
glycyrrhizin
major
compon
glycyrrhiza
glabra
root
concentr
glycyrrhizin
glycosyl
saponin
contain
one
molecul
glycyrretin
acid
structur
similar
hydrocortison
two
molecul
glucuron
acid
attribut
numer
pharmacolog
effect
like
antiinflammatori
antivir
antitumor
hepatoprotect
activ
shown
gl
inhibit
inflamm
mice
model
liver
injuri
present
studi
undertaken
studi
effect
gl
hcv
liver
cell
report
gl
effect
inhibit
hcv
full
length
viral
particl
hcv
core
gene
rna
protein
express
dosedepend
manner
cell
local
patient
serum
sampl
use
investig
obtain
camb
center
appli
molecular
biolog
diagnost
laboratori
lahor
pakistan
serum
sampl
store
prior
viral
inocul
experi
quantif
genotyp
assess
camb
diagnost
laboratori
lahor
pakistan
patient
written
consent
approv
studi
obtain
institut
ethic
committe
cell
line
offer
dr
zafar
nawaz
biochemistri
molecular
biolog
depart
univers
miami
usa
cell
cultur
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
iuml
penicillin
streptomycin
atmospher
co
construct
express
plasmid
viral
rna
isol
serum
aliquot
use
gentra
rna
isol
kit
gentra
system
pennsylvania
usa
accord
manufactur
instruct
ng
extract
viral
rna
use
rtpcr
use
superscript
iii
onestep
rtpcr
system
invitrogen
life
technolog
usa
hcv
complementari
dna
cdna
encod
full
length
core
protein
amino
acid
amplifi
clone
mammalian
express
plasmid
kindli
provid
dr
zafar
nawaz
univers
miami
usa
flag
tag
insert
end
core
gene
ecorv
xbai
restrict
site
trypan
blue
dye
use
confirm
viabil
cho
cell
toxicolog
analysi
gl
liver
cell
seed
densiti
six
well
plate
first
well
consid
control
ad
differ
concentr
gl
lowest
highest
remain
well
h
trypsin
cell
prepar
suspens
cell
suspens
trypan
blue
dye
dispens
glass
slide
count
viabl
cell
haemocytomet
cell
line
use
establish
invitro
replic
hcv
similar
protocol
use
viral
inocul
establish
zekari
et
al
elawardi
et
al
high
viral
titer
iuml
patient
use
principl
inoculum
experi
cell
maintain
cultur
plate
semiconflu
wash
twice
serumfre
medium
inocul
iuwel
serum
free
media
cell
maintain
overnight
co
next
day
adher
cell
wash
three
time
pb
complet
medium
ad
incub
continu
hr
cell
harvest
assess
viral
rna
quantif
real
time
pcr
analyz
effect
gl
hcv
infect
serum
infect
cell
seed
three
day
infect
plate
presenc
absenc
gl
grown
confluenc
ml
medium
h
cell
total
rna
isol
use
gentra
rna
isol
kit
gentra
system
pennsylvania
usa
accord
manufactur
instruct
brief
cell
lyse
cell
lysi
solut
contain
intern
control
sacac
biotechnolog
caserta
itali
rna
pallet
solubil
depc
diethyl
pyrocarbon
treat
water
hcv
rna
quantif
determin
real
time
pcr
smart
cycler
ii
system
cepheid
sunnyval
usa
use
sacac
hcv
quantit
analysi
kit
sacac
biotechnolog
caserta
itali
accord
manufactur
instruct
follow
formula
use
calcul
concentr
hcv
rna
sampl
determin
protein
express
level
hcv
core
transfect
nontransfect
cell
lyse
proteojet
mammalian
cell
lysi
reagent
fermenta
canada
equal
amount
total
protein
subject
electrophoresi
sdspage
electrophoret
transfer
nitrocellulos
membran
follow
manufactur
protocol
biorad
ca
block
nonspecif
bind
site
skim
milk
blot
incub
primari
monoclon
antibodi
specif
hcv
core
gapdh
santa
cruz
biotechnolog
inc
usa
secondari
horseradish
peroxidaseconjug
antigoat
antimous
antibodi
sigma
aldrich
usa
protein
express
evalu
use
chemiluminesc
detect
kit
sigma
aldrich
usa
toxicolog
studi
gl
liver
fibroblast
cell
cytotox
effect
gl
analyz
h
incub
cho
cell
concentr
cell
viabil
evalu
use
viabil
dye
count
cell
haemocytomet
figur
show
cytotox
analysi
gl
demonstr
cho
cell
viabil
unaffect
concentr
howev
exce
toxic
effect
liver
fibroblast
cell
observ
data
verifi
microscop
examin
cell
mtt
cell
prolifer
assay
demonstr
gl
toxic
effect
concentr
data
shown
determin
antivir
effect
gl
cell
plate
densiti
cell
six
well
plate
h
cell
infect
hcv
viru
copi
genotyp
presenc
absenc
differ
concentr
gl
cell
incub
co
incub
addit
h
end
incub
cell
lyse
cell
lysi
solut
total
rna
extract
gentra
rna
isol
kit
hcv
titer
determin
real
time
rt
pcr
hcv
specif
label
primer
result
studi
demonstr
gl
antivir
effect
hcv
dosedepend
manner
figur
real
time
rtpcr
result
exhibit
gl
result
reduct
hcv
concentr
concentr
viral
inhibit
gl
reach
dose
respons
analysi
synergist
effect
gl
check
along
interferon
cell
seed
cell
per
well
plate
dmem
medium
supplement
fb
preincub
h
cell
treat
iu
ifnalpha
h
incub
hcv
addit
h
effect
compound
test
without
interferon
viral
titer
quantifi
quantit
rtpcr
figur
show
gl
exhibit
reduct
viral
titer
alon
gl
combin
interferon
result
reduct
viral
titer
determin
antivir
effect
hcv
core
gene
cell
transfect
hcv
core
gene
presenc
absenc
differ
concentr
gl
h
rna
extract
triazol
invitrogen
cdna
gener
oligo
dt
primer
cdna
amplifi
pcr
use
primer
specif
hcv
core
gene
genotyp
amplif
gapdh
mrna
serv
intern
control
figur
demonstr
gl
inhibit
hcv
rna
protein
express
significantli
dosedepend
manner
gapdh
mrna
protein
express
remain
unaffect
addit
gl
hcv
infect
seriou
global
health
problem
necessit
effect
treatment
current
vaccin
avail
prevent
hcv
infect
due
high
degre
strain
variat
current
treatment
care
pegyl
interferon
combin
ribavirin
costli
signific
side
effect
fail
cure
half
infect
henc
need
develop
antihcv
agent
herbal
synthet
chemistri
less
toxic
efficaci
costeffect
previou
studi
demonstr
medicin
plant
use
centuri
differ
diseas
includ
viral
diseas
becom
focal
point
identifi
isol
purifi
new
compound
treat
diseas
hepat
mani
tradit
medicin
plant
herb
report
strong
antivir
activ
dna
rna
virus
inhibit
viru
replic
interf
virustocel
bind
immunomodul
action
hcv
structur
protein
core
nonstructur
protein
proteas
rnadepend
rna
polymeras
potent
molecular
target
new
antivir
compound
gl
licoric
root
extract
antiinflammatori
antioxid
activ
gl
inhibit
tcell
tumor
necrosi
factor
tnf
mediat
cytotox
gl
membran
stabil
effect
also
stimul
endogen
product
interferon
glycyrrhetin
acid
activ
constitu
glycyrrhiz
acid
show
antivir
activ
number
dna
rna
virus
possibl
due
activ
nfb
induct
secret
gl
use
japan
year
oral
intraven
drug
stronger
neominophagen
c
snmc
oral
gl
metabol
intestin
compound
call
glycyrrhetin
acid
ga
intraven
gl
metabol
glycyrrhetin
acid
excret
bile
intestin
gl
glycyrrhetin
acid
test
hepat
b
cwith
interest
result
previou
studi
report
gl
antivir
activ
hiv
inhibit
viru
replic
interf
virustocel
bind
celltocel
infect
induc
ifn
activ
gl
report
antivir
effect
herpesvirida
famili
virus
vzv
eb
cmv
flavivirus
inhibit
replic
viru
gl
also
antivir
effect
emerg
virus
sar
inhibit
viru
replic
product
synthas
result
studi
show
gl
antivir
effect
hcv
non
toxic
concentr
firstli
gl
check
toxicolog
analysi
cho
cell
line
data
show
gl
non
toxic
concentr
figur
data
verifi
microscop
examin
cell
mtt
cell
prolifer
assay
guha
et
al
report
vitro
cell
cultur
model
best
demonstr
infect
viru
use
evalu
drug
antivir
activ
inhibit
hcv
infect
studi
world
conduct
deriv
cell
line
replicon
support
hcv
rna
transcript
protein
synthesi
recent
differ
group
studi
hcv
replic
serum
infect
liver
cell
line
studi
differ
hcv
genotyp
mimic
natur
occur
hcv
virion
biolog
kinet
hcv
infect
human
infect
cell
nativ
viral
particl
hcv
posit
serum
preval
type
pakistan
use
protocol
establish
result
data
demonstr
gl
antivir
effect
hcv
dosedepend
manner
figur
result
prove
gl
show
reduct
hcv
concentr
concentr
viral
inhibit
gl
reach
hcv
core
protein
modul
gene
transcript
cell
prolifer
cell
death
cell
signal
interfer
metabol
gene
suppress
host
immun
respons
lead
oxid
stress
liver
steatosi
eventu
hepatocellular
carcinoma
core
protein
also
abl
upregul
express
hepatocyt
deriv
cell
provid
potenti
mechan
oxid
stress
express
hcc
found
correl
level
sever
key
molecul
implic
carcinogenesi
induc
nitric
oxid
synthetas
ino
activ
vascular
endotheli
growth
factor
vegf
phosphoryl
akt
pakt
data
show
gl
inhibit
hcv
core
gene
express
function
dosedepend
manner
similar
interferon
alpha
may
due
stimul
interferon
pathway
phosphoryl
tyrosin
serin
gl
may
show
antivir
effect
due
abil
reduc
membran
fluiditi
regul
relat
pathway
gl
inhibit
hcv
full
length
viral
particl
hcv
core
gene
express
rna
protein
level
synergist
effect
interferon
therefor
also
specul
pilot
studi
therapeut
induct
gl
either
alon
combin
ifn
treatment
might
repres
altern
approach
futur
treatment
chronic
infect
hcv
hepat
c
viru
gl
glycyrrhizin
human
hepatoma
cell
line
